peter attia bpc 157 387 - AMA #83: Peptides—evaluating the science, safety, and hype in a rapidly growing field Podcasts — Hale Men's Clinic

Demographics Known risk factors and demographics for neuropathic pains include female sex, younger age, higher BMI, smoking history, manual or personal service occupations, lower socioeconomic status, and ethnic minority status, along with medical conditions such as diabetes, peripheral neuropathy, musculoskeletal disorders (such as rheumatoid arthritis, osteoarthritis, and fibromyalgia)

No regulatory authority Health Canada, the FDA, the EMA, the TGA, or any equivalent has cleared 5-Amino-1MQ for therapeutic use in humans or animals

Clinical trials tested doses ranging from 250mcg to 1mg daily, with most protocols settling around 300-500mcg for optimal fat metabolism support

Norman: University of Oklahoma Press, 1946

So, if you do regularly have soya, or cut it out because you thought it could affect your treatment, feel free to carry on consuming it as part of a well-balanced diet

Buy AOD-9604 EUROPE available in 2mg, 5mg and 10 mg Peptide Vials for research use only